Subunit vaccination benefits from improved safety over attenuated or inactivated vaccines,
but their limited capability to elicit long-lasting, concerted cellular and humoral immune …

Drug delivery systems (DDSs) face several challenges including site-specific delivery,
stability, and the programmed release of drugs. Engineered nanoparticle (NP) surfaces with …

Inflammation is an immune response that marks several pathophysiological conditions in
our body. Though adaptive immune cells play a major role in the progression of the disease …

Immunotherapy has recently garnered plenty of attention to improve the clinical outcomes in
the treatment of various diseases. However, owing to the dynamic nature of the immune …

There is a wide range of methods and technologies aimed at improving human vaccine
products and the way they are delivered. Some of these have the potential to increase …

Therapeutic vaccination offers great promise as an intervention for a diversity of infectious
and non‐infectious conditions. Given that most chronic health conditions are thought to have …

Therapeutic immunomodulation in the skin, its draining lymph nodes, or both tissues
simultaneously using an intradermal administration scheme is desirable for a variety of …

Cancer vaccines represent among the most promising strategies in the battle against
cancers. However, the clinical efficacy of current cancer vaccines is largely limited by the …

Antigen-specific immunotherapy combats autoimmunity or allergy by reinstating
immunological tolerance to target antigens without compromising immune function …

Nanoparticles represent a new generation of drug delivery systems that can be engineered
to harness optimal target selectivity for specific cells and tissues and high drug loading …